DUBLIN (AP) _ Amarin Corp. PLC (AMRN) on Tuesday reported a loss of $27.5 million in its fourth quarter.
On a per-share basis, the Dublin-based company said it had a loss of 10 cents. Losses, adjusted for pretax expenses and stock option expense, were 4 cents per share.
The biopharmaceutical company posted revenue of $38.7 million in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $36.3 million.
For the year, the company reported that its loss narrowed to $86.4 million, or 41 cents per share. Revenue was reported as $130.1 million.
The company's shares closed at $3.43. A year ago, they were trading at $1.41.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMRN at https://www.zacks.com/ap/AMRN
Keywords: Amarin, Earnings Report